James Webb v. Solarcity Corporation
884 F.3d 844
9th Cir.2018Background
- SolarCity sold and leased solar systems; leases/PPA revenues are recognized ratably over ~20 years while sales revenues are recognized on installation, with different cost allocation rules under GAAP.
- From Q1 2012 through seven quarters, SolarCity misapplied its burden-ratio formula by omitting prior-period direct costs from the denominator, which shifted overhead onto leases and inflated reported sales gross margins and earnings.
- The company went public in Dec. 2012 and made large financings and acquisitions in 2013; the accounting error was disclosed in March 2014, followed by restatements and a stock price decline.
- Plaintiff James Webb filed a § 10(b)/Rule 10b-5 class action (and § 20(a) against Rive and Kelly) alleging the accounting change was intentional fraud to overstate profitability around the IPO; Webb amended his complaint three times.
- The district court dismissed the Third Amended Complaint (TAC) for failure to plead scienter with particularity; the Ninth Circuit affirmed.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Whether TAC pleads scienter for § 10(b)/Rule 10b-5 | Webb: Defendants intentionally changed burden-ratio to misstate profitability; CWs, motive, GAAP violations, SOX certifications, and core-operations inference support a strong inference of intent or deliberate recklessness | SolarCity/Rive/Kelly: Facts at best show mismanagement or an honest accounting error; allegations are not particularized or as compelling as nonfraudulent inference | Held: Pleading fails—inference of honest mistake is more compelling; scienter not adequately pleaded |
| Admissibility/weight of confidential witness (CW) allegations | CWs describe poor controls, knowledge of negative sales margins, and management awareness | Defendants: Many CWs predate class period or lack access to the specific burden-ratio calculation; testimony is insufficiently particular | Held: CW statements considered but, even collectively, insufficient to establish scienter |
| Whether motive/alleged personal gain supports scienter | Webb: Defendants had motive to inflate stock (IPO proceeds, acquisitions, personal holdings, and alleged pressure to help Musk avoid margin risk) | Defendants: Motive allegations are generic corporate objectives and speculative; no personalized, particularized motive tied to misconduct | Held: Motive allegations are insufficient and unparticularized; do not establish scienter |
| Applicability of core-operations inference | Webb: Burden-ratio and sales margins concern core operations; management was hands-on so they must have known about the accounting change | Defendants: No allegations that executives controlled minutiae of burden-ratio calculation or had actual access to the formula; error was subtle and missed by accountants and auditors | Held: Core-operations inference not satisfied; plaintiffs failed to allege executives’ actual involvement or that nonknowledge would be absurd |
Key Cases Cited
- Tellabs, Inc. v. Makor Issues & Rights, Ltd., 551 U.S. 308 (establishes the PSLRA "strong inference" standard for scienter)
- Matrixx Initiatives, Inc. v. Siracusano, 563 U.S. 27 (elements of a § 10(b)/Rule 10b-5 claim)
- In re VeriFone Holdings, Inc. Sec. Litig., 704 F.3d 694 (9th Cir. 2012) (holistic assessment of scienter allegations)
- City of Dearborn Heights Act 345 Police & Fire Ret. Sys. v. Align Tech., Inc., 856 F.3d 605 (9th Cir. 2017) (deliberate recklessness standard)
- In re Quality Sys., Inc. Sec. Litig., 865 F.3d 1130 (9th Cir. 2017) (pleading scienter via intent or deliberate recklessness)
- Schueneman v. Arena Pharm., 840 F.3d 698 (9th Cir. 2016) (scienter and deliberate recklessness discussion)
- Zucco Partners, LLC v. Digimarc Corp., 552 F.3d 981 (9th Cir. 2009) (core-operations inference and executive involvement requirements)
- S. Ferry LP, No. 2 v. Killinger, 542 F.3d 776 (9th Cir. 2008) (management-role allegations in scienter analysis)
- In re Daou Sys., Inc., 411 F.3d 1006 (9th Cir. 2005) (restatement magnitude may bear on scienter)
- In re Merck & Co. Sec. Litig., 432 F.3d 261 (3d Cir. 2005) (use of pre-class-period witness statements to show what defendants should have known)